Markus H. Heim
Impact in
- Hepatology top 0.1%
- Hepatitis C virus research
- Cancer Research top 0.5%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
Papers in
- Hepatology 110
- Hepatitis C virus research 80
- Hepatocellular Carcinoma Treatment and Prognosis 14
- Immunology 48
- interferon and immune responses 26
- Immune Cell Function and Interaction 14
- Co-authors
- Urs MeyerLuigi TerraccianoFrançois H.T. DuongThomas ScheibelMagdalena Filipowicz SinnreichDarius MoradpourVerena ChristenDavid Keerl
- Journals
- Hepatology (23 papers)Journal of Hepatology (21 papers)PLoS ONE (8 papers)Journal of Virology (7 papers)Gastroenterology (7 papers)
- Partner nations
- SwitzerlandGermanyUnited States
In The Last Decade
Markus H. Heim
216 papers receiving 15.4k citations
Hit Papers
Peers
Comparison fields: 5 of 156
- Hepatology 4.7k
- Cancer Research 2.7k
- Pharmacology 1.2k
- Epidemiology 4.5k
- Immunology 2.6k
Countries citing papers authored by Markus H. Heim
This map shows the geographic impact of Markus H. Heim's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Markus H. Heim with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Markus H. Heim more than expected).
Fields of papers citing papers by Markus H. Heim
This network shows the impact of papers produced by Markus H. Heim. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Markus H. Heim. The network helps show where Markus H. Heim may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Markus H. Heim, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 6 | |
| 2 | 2023 | 28 | |
| 3 | 2022 | 88 | |
| 4 | 2022 | 3 | |
| 5 | 2021 | 13 | |
| 6 | 2021 | 9 | |
| 7 | 2021 | 7 | |
| 8 | 2021 | 10 | |
| 9 | 2021 | 87 | |
| 10 | 2020 | 162 | |
| 11 | 2018 | 13 | |
| 12 | 2017 | 16 | |
| 13 | 2017 | 3 | |
| 14 | 2016 | 54 | |
| 15 | 2013 | 10 | |
| 16 | the Swiss Hepatitis C Cohort Study Group | 2011 | 2 |
| 17 | 2011 | 1 | |
| 18 | Interferon signaling and treatment outcome in chronic hepatitis C Hit paper breakdown → | 2008 | 520 |
| 19 | 2008 | 1 | |
| 20 | 2003 | 137 |
About Markus H. Heim
Markus H. Heim is a scholar working on Hepatology, Immunology, Epidemiology, Oncology and Pharmacology, having authored 222 papers that have together received 15.7k indexed citations. Recurring topics across this work include Hepatitis C virus research (80 papers), Liver Disease Diagnosis and Treatment (52 papers), Hepatitis B Virus Studies (31 papers), Cytokine Signaling Pathways and Interactions (27 papers), interferon and immune responses (26 papers), Systemic Lupus Erythematosus Research (15 papers), Immune Cell Function and Interaction (14 papers) and Hepatocellular Carcinoma Treatment and Prognosis (14 papers). The work is most often cited by research in Hepatology (4.7k citations), Cancer Research (2.7k citations), Pharmacology (1.2k citations), Epidemiology (4.5k citations) and Immunology (2.6k citations). Markus H. Heim has collaborated with scholars based in Switzerland, Germany and United States. Frequent co-authors include Urs Meyer, Luigi Terracciano, François H.T. Duong, Thomas Scheibel, Magdalena Filipowicz Sinnreich, Darius Moradpour, Verena Christen, David Keerl, Stefan Wieland and Martin Blum. Their work appears in journals such as Hepatology, Journal of Hepatology, PLoS ONE, Journal of Virology and Gastroenterology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.